Global Pharmaceuticals & Biotech Most Popular Stocks

PharmaEssentia

Market Cap: NT$191.9b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Yuhan

Market Cap: ₩8.8t

Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.

Avidity Biosciences

Market Cap: US$6.2b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Shanghai RAAS Blood Products

Market Cap: CN¥44.2b

Engages in the manufacture and sale of blood products in China.

ABIVAX Société Anonyme

Market Cap: €5.3b

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

Legend Biotech

Market Cap: US$6.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Axsome Therapeutics

Market Cap: US$5.9b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Hebei Changshan Biochemical Pharmaceutical

Market Cap: CN¥41.6b

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

SK Biopharmaceuticals

Market Cap: ₩8.2t

A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.

Cytokinetics

Market Cap: US$5.8b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Nuvalent

Market Cap: US$5.7b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Shanghai Junshi Biosciences

Market Cap: HK$43.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

Semnur Pharmaceuticals

Market Cap: US$5.6b

Develops and markets non-opioid drugs to treat back pain.

CRISPR Therapeutics

Market Cap: US$5.6b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Asymchem Laboratories (Tianjin)

Market Cap: CN¥39.6b

Asymchem Laboratories (Tianjin) Co., Ltd.

Metsera

Market Cap: US$5.5b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Laurus Labs

Market Cap: ₹485.8b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

Bachem Holding

Market Cap: CHF 4.4b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Ono Pharmaceutical

Market Cap: JP¥801.7b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Biocon

Market Cap: ₹473.7b

Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt

Market Cap: Ft1.8t

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

Beijing Tiantan Biological Products

Market Cap: CN¥37.6b

Beijing Tiantan Biological Products Co., Ltd.

Dottikon ES Holding

Market Cap: CHF 4.2b

Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries worldwide.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹463.0b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Shanghai Henlius Biotech

Market Cap: HK$40.3b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

TG Therapeutics

Market Cap: US$5.2b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Merus

Market Cap: US$5.2b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Anthem Biosciences

Market Cap: ₹450.3b

Operates as technology-focused contract research, development, and manufacturing organization.

Zealand Pharma

Market Cap: DKK 31.7b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥34.8b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Humanwell Healthcare (Group)Ltd

Market Cap: CN¥34.8b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

Bruker

Market Cap: US$4.9b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Chengdu Kanghong Pharmaceutical Group

Market Cap: CN¥34.0b

Research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China.

Xiamen Amoytop Biotech

Market Cap: CN¥34.0b

Engages in research, development, production, and sale of recombinant protein drugs in China.

PTC Therapeutics

Market Cap: US$4.7b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Hikma Pharmaceuticals

Market Cap: UK£3.5b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.